[144] APi Group Corporation SEC Filing
APi Group Corporation (APG) filed a Form 144 disclosing a proposed sale of 1,200,000 shares of common stock through Merrill Lynch on the NYSE, with an aggregate market value of $41,567,614.80 and approximately 415,888,477 shares outstanding. The shares were acquired as partnership distributions from API Group Corp on 10/05/2017 (951,025 shares) and 10/02/2019 (248,975 shares). The notice states there were no sales in the past three months and includes the required representation that the seller has no undisclosed material information.
- Full disclosure of sale details including broker, number of shares, aggregate market value, and planned sale date
- Clear provenance of shares with acquisition dates and amounts from partnership distributions (10/05/2017 and 10/02/2019)
- No sales in past three months reported, indicating this is the current disclosed liquidity event
- Sizeable proposed sale: 1,200,000 shares with an aggregate market value of $41,567,614.80 could be material to trading supply
Insights
TL;DR: Large block sale disclosed: 1.2M shares valued at $41.6M via Merrill Lynch may affect supply dynamics.
The filing is a standard Rule 144 notice reporting a proposed sale of 1,200,000 common shares on 09/02/2025 with an aggregate market value of $41,567,614.80. Acquisition dates and amounts are provided, showing the shares originated from partnership distributions in 2017 and 2019. There were no reported sales in the prior three months, which suggests this filing is the primary near-term liquidity event disclosed by the seller. For investors, the key takeaways are the size and timing of the proposed sale and the broker handling the transaction.
TL;DR: The filer complied with Rule 144 disclosure requirements and certified absence of undisclosed material information.
The notice includes required identification of the securities, broker (Merrill Lynch), exact share counts acquired via partnership distribution, and a representation that the seller is not aware of undisclosed material adverse information. The filing also notes no securities were sold in the past three months. From a governance perspective, the filing demonstrates procedural compliance with transfer and insider-sale disclosure obligations.